Abbott Laboratories (BCBA:ABT)

Abbott Laboratories Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	300,385,821	202,265,940	154,491,179	33,906,310	24,785,975	15,775,304
Market Cap Growth	71.06%	30.92%	355.64%	36.80%	57.12%	71.52%
Enterprise Value	308,821,811	209,988,130	161,658,371	35,125,277	25,702,082	16,956,011
Last Close Price	43575.00	33240.94	26194.63	9171.48	6905.92	3742.47
PE Ratio	18.10	14.69	33.52	27.72	34.28	41.94
PS Ratio	5.85	4.68	4.76	4.39	5.60	5.42
PB Ratio	4.96	4.10	4.92	5.19	6.70	5.68
P/TBV Ratio	12.18	10.96	31.28	55.76	-	-
P/FCF Ratio	-	30.89	37.77	24.53	27.91	32.77
P/OCF Ratio	-	22.92	26.32	19.98	22.92	23.74
EV/Sales Ratio	5.48	4.86	4.99	4.54	5.81	5.83
EV/EBITDA Ratio	19.98	19.01	19.11	16.02	19.64	22.94
EV/EBIT Ratio	28.42	27.17	27.69	21.76	27.19	36.92
EV/FCF Ratio	38.25	32.07	39.52	25.41	28.94	35.23
Debt / Equity Ratio	0.27	0.32	0.41	0.49	0.53	0.60
Debt / EBITDA Ratio	1.14	1.38	1.47	1.41	1.47	2.18
Debt / FCF Ratio	1.99	2.40	3.14	2.30	2.23	3.48
Asset Turnover	0.55	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	2.74	2.92	2.81	3.37	3.56	3.22
Quick Ratio	1.14	1.05	1.00	1.06	1.28	1.14
Current Ratio	1.82	1.67	1.64	1.63	1.85	1.72
Return on Equity (ROE)	30.93%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	6.62%	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Capital (ROIC)	8.75%	7.95%	8.24%	10.34%	10.64%	6.61%
Return on Capital Employed (ROCE)	11.80%	11.10%	12.20%	15.50%	14.80%	9.00%
Earnings Yield	5.53%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	2.69%	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	0.95%	6.95%	6.42%	3.71%	2.71%	3.44%
Payout Ratio	28.42%	28.62%	62.13%	47.73%	45.28%	56.95%
Buyback Yield / Dilution	0.08%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Shareholder Return	1.03%	7.00%	7.27%	5.10%	2.54%	3.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.